Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

2nd Annual Pharma Law Convention, 13-14 March 2013, Prague, Czech Republic

Date: Oct-31-2012
The 2nd Annual Pharma Law Convention is set to take place next year in Prague, Czech republic, on March 13th - 14th and follows the success of the pilot 2012 convention that took place in April in Bratislava, Slovakia.

The Convention will once again offer its guests and participants a quality program mentored and advised by a number of leading regulatory national and EU bodies, professional industry organizations and some of Europe's leading legal advisers on the subjects to be introduced:
Compliance / Transparency
Competition
Parallel Trade

The Convention once again will offer detailed discussions and presentations over the regulatory and legal aspects of these subjects applied to the pharmaceutical sector in Europe. The program will place more practical emphasis on the CEE countries in which the given subjects are in strong demand for further regulatory development.

Among the guests key note speakers will be Mr. Richard Bergstrom from EFPIA and Mr. Blaz Visnar from DG Competition. In addition a number of Europe's leading legal firms have confirmed their presence and involvement in the program (Baker & McKenzie / DLA Piper). This Convention will also host a number of exclusive guest speakers from national regulators from Poland, Czech Rep., Slovakia and Hungary who will support the discussions with input and insights about their countries challenges to be solved.

The Convention will once again offer its exclusive offer to all industry guests offering symbolic access to its program. For all types of inquires about the program, delegate seats and speaking opportunities please visit http://www.lawconvention.eu, contact us at office@lawconvention.eu or 00421 914 228 236.
Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.